Keyword Filter

Optimal Combinations of Broadly Neutralizing Antibodies for Prevention & Therapy of HIV-1 Clade C Infection

Keystone Symposia SciTalks:

Optimal Combinations of Broadly Neutralizing Antibodies for Prevention & Therapy of HIV-1 Clade C Infection


Recorded: March 20 - 24, 2016

Keystone Symposia meeting: HIV Vaccines [X8]

Location: Resort at Squaw Creek, Olympic Valley, CA


a5185dcd0dd90f06d35754b33530af6c.png



___

About Keystone Symposia:

Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists.

Website: www.keystonesymposia.org




A novel conserved-region T-cell mosaic vaccine with very globale coverage of HIV-1 variants is recognized by protective responses in chronic untreated infection

Keystone Symposia SciTalks:

A novel conserved-region T-cell mosaic vaccine with very globale coverage of HIV-1 variants is recognized by protective responses in chronic untreated infection


Recorded: March 20 - 24, 2016

Keystone Symposia meeting: HIV Vaccines [X8]

Location: Resort at Squaw Creek, Olympic Valley, CA


c4e08c8e8923613e37046f6b05573d3a.png


___

Copyright Keystone Symposia, 2017. All rights reserved.

About Keystone Symposia:

Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists.

Website: www.keystonesymposia.org




Tumor neoantigens identificsation and formulation testing for therapeutic vaccines development to treat cancer


Migration-induced shattering due to DOCK8-deficiancy causes a type-2 biased helper T cell response


Developing a collaborative network to study TB and HIV biomarkers

Developing a collaborative network to study TB and HIV biomarkers

Dr. Andrade lab is dedicated to identifying reliable host biomarkers that can predict susceptibility to infection and disease severity in tuberculosis (TB) and HIV. By establishing a strong network of collaborators from different TB endemic countries, such as India, China, South Africa and Brazil, his group has designed cohort studies in which synchronization of clinical and immunologic data collection results in validation of biomarker findings across countries. In addition, the Andrade Lab performs integrative analyses merging epidemiologic, socioeconomic, clinical, immunologic, microbiologic and geographic data to more robustly describe the TB determinants and help to delineate more reliable decision-making strategies.

At the edge of survival: Genetic associations for cell death in pemphigus foliaceus


Engineering Adoptive T Cell Therapy for Efficacy in Ovarian Cancer [SHORT TALK]

Recorded during the Keystone Symposia meeting:



Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology



Mar 19 - Mar 23, 2017 | Whistler, British Columbia, Canada


Why Mosquitoes Matter

Recorded on February 19, 2017


Pre Meeting Workshop

Malaria: From Innovation to Eradication

Feb 19 - Feb 23, 2017 | Kampala, Uganda


View and Download Presentation


This Keystone Symposia SciTalk was made possible by a grant from the

adbba4181558e79ea25f0f0ee4c31047.png



The goal of the pre meeting workshop is to provide valuable background on what to expect for the upcoming Keystone Symposia. The intent is to bring participants up to speed on the concepts to be presented at the meeting and enable the them to maximize their experience.



Leishmania parasites and their viral force


The Genome Editing Revolution - Translating Genome Editing Technologies into Human Therapies

Keystone Symposia Live Panel:
The Genome Editing Revolution: Translating Genome Editing Technologies into Human Therapies


Recent advances in genome editing nucleases have led to their broader application in biomedical research and dramatically accelerated efforts to develop therapeutics based on this technology. In this dynamic, interactive panel event, experts in genome editing and gene therapy from academia and industry will discuss the following topics and others relevant to clinical translation of the technology:

  • What are the most important recent basic science and technological advances and biggest impacts in the field of genome editing that will substantially advance the prospects of gene-based therapy?
  • How can the experiences of the gene therapy field inform the development of genome editing therapeutics?
  • What are the risks and biggest obstacles that must be minimized and overcome to successfully translate genome editing into human therapeutics?
  • Which diseases are the most promising candidates to benefit from genome editing therapies?
  • What impact, if any, has the CRISPR IP dispute had on developing gene-based therapeutics?


ab60130c705a512e401f8efd30e5b59f.png
___

Copyright Keystone Symposia, 2017. All rights reserved.

About Keystone Symposia:
Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists.

Website: www.keystonesymposia.org